(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(0.13%) $82.74
(1.13%) $2.05
(-0.47%) $2 346.60
(-0.92%) $27.41
(-0.24%) $959.20
(-0.18%) $0.933
(-0.30%) $10.99
(-0.54%) $0.796
(1.56%) $93.31
3 days till quarter result
(bmo 2024-05-02)
Expected move: +/- 6.43%
Live Chart Being Loaded With Signals
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita Open Plus and E-vita Open Neo...
Stats | |
---|---|
Dagens volum | 82 998.00 |
Gjennomsnittsvolum | 218 693 |
Markedsverdi | 859.22M |
EPS | $0 ( 2024-02-15 ) |
Neste inntjeningsdato | ( $0.0200 ) 2024-05-02 |
Last Dividend | $0.0300 ( 2015-12-09 ) |
Next Dividend | $0 ( N/A ) |
P/E | -27.47 |
ATR14 | $0.0220 (0.11%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-20 | Stanton Marshall S. | Sell | 2 183 | Common Stock |
2024-03-15 | Green Andrew M | Sell | 1 462 | Common Stock |
2024-03-14 | Green Andrew M | Sell | 3 994 | Common Stock |
2024-03-12 | Getz Matthew A | Sell | 5 000 | Common Stock |
2024-02-23 | Horton Amy | Buy | 6 418 | Common Stock |
INSIDER POWER |
---|
41.06 |
Last 100 transactions |
Buy: 409 992 | Sell: 170 182 |
Volum Korrelasjon
Artivion, Inc. Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
BRF | 0.858 |
DEX | 0.846 |
GREK | 0.842 |
NTZ | 0.837 |
UBER | 0.836 |
RCL | 0.835 |
NTCO | 0.835 |
TWN | 0.829 |
IXSE | 0.828 |
QPX | 0.828 |
10 Mest negative korrelasjoner | |
---|---|
CGC | -0.844 |
RENN | -0.837 |
RLX | -0.831 |
QID | -0.825 |
PSQ | -0.823 |
LGF-A | -0.821 |
LGF-B | -0.821 |
SSG | -0.819 |
IDT | -0.819 |
BZQ | -0.818 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Artivion, Inc. Korrelasjon - Valuta/Råvare
Artivion, Inc. Økonomi
Annual | 2023 |
Omsetning: | $354.00M |
Bruttogevinst: | $213.98M (60.45 %) |
EPS: | $-0.750 |
FY | 2023 |
Omsetning: | $354.00M |
Bruttogevinst: | $213.98M (60.45 %) |
EPS: | $-0.750 |
FY | 2022 |
Omsetning: | $313.79M |
Bruttogevinst: | $202.52M (64.54 %) |
EPS: | $-0.480 |
FY | 2021 |
Omsetning: | $298.84M |
Bruttogevinst: | $197.51M (66.09 %) |
EPS: | $-0.392 |
Financial Reports:
No articles found.
Artivion, Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.0250 | 2012-09-12 |
Last Dividend | $0.0300 | 2015-12-09 |
Next Dividend | $0 | N/A |
Payout Date | 2015-12-18 | |
Next Payout Date | N/A | |
# dividends | 14 | -- |
Total Paid Out | $0.395 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.54 | -- |
Div. Sustainability Score | 3.78 | |
Div.Growth Potential Score | 2.22 | |
Div. Directional Score | 3.00 | -- |
Year | Amount | Yield |
---|---|---|
2012 | $0.0500 | 1.04% |
2013 | $0.108 | 1.61% |
2014 | $0.118 | 1.06% |
2015 | $0.120 | 1.07% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
MTR | Dividend Diamond | 2023-10-30 | Monthly | 39 | 10.10% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
PDI | Dividend Royal | 2023-11-10 | Monthly | 13 | 7.86% | 8.50 |
ZTR | Dividend King | 2024-02-09 | Monthly | 37 | 8.35% | 8.50 |
ORC | Dividend Royal | 2023-11-29 | Monthly | 12 | 9.23% | 8.50 |
KIO | Dividend Royal | 2023-12-14 | Monthly | 12 | 7.05% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0867 | 1.500 | -1.734 | -2.60 | [0 - 0.5] |
returnOnAssetsTTM | -0.0387 | 1.200 | -1.291 | -1.549 | [0 - 0.3] |
returnOnEquityTTM | -0.110 | 1.500 | -2.33 | -3.50 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 3.99 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 2.30 | 0.800 | 1.177 | 0.942 | [0.8 - 2.5] |
cashRatioTTM | 1.019 | 1.500 | 5.45 | 8.18 | [0.2 - 2] |
debtRatioTTM | 0.394 | -1.500 | 3.44 | -5.16 | [0 - 0.6] |
interestCoverageTTM | 0.268 | 1.000 | -1.012 | -1.012 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.454 | 2.00 | 9.85 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.273 | 2.00 | 9.86 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 1.107 | -1.500 | 5.57 | -8.36 | [0 - 2.5] |
grossProfitMarginTTM | 0.647 | 1.000 | 2.54 | 2.54 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0192 | 1.000 | -1.617 | -1.617 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.0595 | 1.000 | -0.780 | -0.780 | [0.2 - 2] |
assetTurnoverTTM | 0.447 | 0.800 | -0.355 | -0.284 | [0.5 - 2] |
Total Score | 3.78 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -27.41 | 1.000 | -2.87 | 0 | [1 - 100] |
returnOnEquityTTM | -0.110 | 2.50 | -1.500 | -3.50 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.273 | 2.00 | 9.91 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.454 | 2.00 | 9.85 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.594 | 1.500 | 9.37 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0525 | 1.000 | -1.188 | 0 | [0.1 - 0.5] |
Total Score | 2.22 |
Artivion, Inc.
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita Open Plus and E-vita Open Neo. It also provides E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion Inc. in January 2022. The company was founded in 1984 and is headquartered in Kennesaw, Georgia.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.